About
Basic Data Updated:
1 month agoInd Swift Laboratories Limited is a medium-sized manufacturer of Active Pharmaceuticals Ingredients (APIs) and Advanced Intermediates. The company's presence is mostly in domestic markets and certain semi-regulated markets. Bulk drugs are developed, manufactured, and supplied by the company to various domestic formulations companies and leading generic players across semi-regulated markets, with a presence in East European Markets. The product portfolio of ISLL includes clarithromycin, clarithromycin citrate, letrozole, Nitazoxanide, Mecloxamine Citrate, Ezetimibe, and many more.
Industry
Company Details
- Location
Chandigarh, Chandigarh, India
- Website1222442
- Telephone1222442
- Email Address1222442
- Social Media1222442
CIN/LLPIN/FCRN | L24232CH1995PLC015553 |
Company No. | 015553 |
Stock Symbol | BSE : 532305 NSE : INDSWFTLAB |
Company Classification | Public Limited Indian Non-Government Company |
Incorporation Date | 04 Jan 1995 |
Date of AGM | 30 Sep 2023 |
Date of Balance Sheet | 31 Mar 2023 |
Listing Status | Listed |
ROC Code | Roc Chandigarh |
Products or Services related to Ind Swift Laboratories Limited
Financials of Ind Swift Laboratories Limited
Enhance accessibility to Ind Swift Laboratories's financial data by unlocking access to both Standalone and Consolidated balance sheets, Profit & Loss Statements, Ratios, Related Party Transactions, and additional relevant information.
Corporate Structure
Unlock access to Ind Swift Laboratories's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
People in Ind Swift Laboratories Limited
Unlock and access historical data on people associated with Ind Swift Laboratories, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Executive Team (4)
GA
Gagan Aggarwal CFOStatus: Current
NM
Navrattan Munjal Managing DirectorAppointment Date: 04-Jan-1995
Status: Current
PV
Pardeep Verma Company SecretaryStatus: Current
SD
Sunil Deshmukh CEOStatus: Current
Board Members(7)
Charges (Loans)
Lender | Amount | Status |
---|---|---|
Axis Bank Limited Creation Date: 29 Aug 2023 | ₹1.70 Cr | Open |
Idbi Trusteeship Services Limited Creation Date: 21 Jun 2019 | ₹808.83 Cr | Open |
Others Creation Date: 05 Sep 2018 | ₹75.44 Cr | Open |
Deals i
Gain comprehensive insights into the Deals and Valuation data of Ind Swift Laboratories, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Ind Swift Laboratories's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alert
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Related Corporates (Common Directorship)
Mjm Remedies Private Limited
Active 1 year 10 monthsHimanshu Jain and Navrattan Munjal are mutual person
Fortune (India) Constructions Limited
Active 19 years 2 monthsHimanshu Jain, Sahil Munjal and 1 more are mutual person
Essix Biosciences Limited
Active 30 years 7 monthsHimanshu Jain, Rishav Mehta and 1 more are mutual person
Vibrant Agro Industries Limited
Active 18 years 9 monthsSahil Munjal and Rishav Mehta are mutual person
Recent activity within the organization
Annual General Meeting
Ind Swift Laboratories Limited last Annual general meeting of members was held on 30 Sep 2023 as per latest MCA records.
30 Sep 2023Charges
A charge with Axis Bank Limited amounted to Rs. 1.70 cr with Charge ID 100802248 was registered on 29 Aug 2023.
29 Aug 2023Balance Sheet
Ind Swift Laboratories Limited has filed its annual Financial statements for the year ended 31 Mar 2023 with Roc Chandigarh.
31 Mar 2023Charges
A charge registered on 04 Jan 2012 via Charge ID 10330322 with Others was fully satisfied on 10 Feb 2023.
10 Feb 2023Charges
A charge registered on 30 Oct 2009 via Charge ID 10183686 with Others was fully satisfied on 10 Feb 2023.
10 Feb 2023
Recent News, Updates & Announcement
- India Resurgences Acquisition of API and CRAMS Business of Ind Swift Laboratories.
Global Legal Chronicle 19 Sep 2023
- lndiaRF to acquire API CRAMS business of IndSwift Labs.
IndiaRF will acquire the active pharmaceutical ingredients API and contract research and manufacturing services CRAMS business of IndSwift Labs for a consideration of Rs 1650 crore ET first reported on this transaction on July 21 this year The acquisition will be done through Synthimed Labs a portfolio company of India Resurgence Fund.
Economic Times 06 Sep 2023
- India resurgence fund in talks to acquire IndSwifts API business.
Earlier in July 2021 IndSwift Laboratories had agreed to sell its API business to PI Industries on a slump sale basis for 1530 crore However the deal had been terminated by PI Industries in November 2021 Incorporated in 1995 IISL is engaged in the manufacturing of APIs advanced intermediates and providing Contract Research and Manufacturing Services CRAMS The company has three manufacturing facilities two in Dera Bassi including research facility Punjab and one in Samba Jammu Kashmir.
Economic Times 21 Jul 2023
- IndSwift Laboratories raises Rs 4245 crore via NCDs.
Moneycontrol 13 Jun 2018
Frequently asked questions
What is the Incorporation or founding date of Ind Swift Laboratories Limited?